After six years at the helm of the Medicines and Healthcare products Regulatory Agency (MHRA), Dame June Raine will step down at the end of this month, with Lawrence Tallon steppi ...
Moderna’s respiratory syncytial virus (RSV) vaccine mRESVIA has been approved by the Medicines and Healthcare products ...
"The MHRA's authorization of our RSV vaccine is an important milestone for Moderna's efforts toward respiratory disease preparedness," said Stéphane Bancel, Chief Executive Officer of Moderna. "Our ...
From a historic vaccine approval to a $50bn investment reshaping US drug manufacturing, February brought major pharma news to ...
The Windsor Framework marks a significant change in the UK's post-Brexit regulatory space, particularly for the ...
Britain's health regulator said on Friday it has approved Moderna's vaccine for respiratory syncytial virus in adults 60 ...
CAMBRIDGE, MA / ACCESS Newswire / February 28, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that the Medicines and Healthcare products Regulatory Agency (MHRA) in the UK has granted ...
today announced that the Medicines and Healthcare products Regulatory Agency (MHRA) in the UK has granted marketing authorization for mRESVIA (mRNA-1345), indicated for active immunization for the ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback